Clinical Pharmacology Study of MRA in Patient With Rheumatoid Arthritis (RA) With Renal Impairment

Status:
Completed

Trial end date:
2005-10-01

Target enrollment:

Participant gender:

This is an open-label, clinical pharmacology study to evaluate the safety and PK of MRA in patients with RA with Renal Impairment.

N/A

Chugai Pharmaceutical